APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability
Science Advances · 19.01.2024 · 10 (3)
DOI: 10.1126/sciadv.adk2771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 19.01.2024. Verfasst von Ajinkya S Kawale und 5 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Proteins. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Mutation signatures associated with apolipoprotein B mRNA editing catalytic polypeptide-like 3A/B (APOBEC3A/B) cytidine deaminases are prevalent across cancers, implying their roles as mutagenic drivers during tumorigenesis and tumor evolution. APOBEC3A (A3A) expression induces DNA replication stress and increases the cellular dependency on the ataxia telangiectasia and Rad3-related (ATR) kinase for survival. Nonetheless, how A3A induces DNA replication stress remains unclear. We show that A3A induces replication stress without slowing replication forks. We find that A3A induces single-stranded DNA (ssDNA) gaps through PrimPol-mediated repriming. A3A-induced ssDNA gaps are repaired by multiple pathways involving ATR, RAD51, and translesion synthesis. Both ATR inhibition and trapping of poly(ADP-ribose) polymerase (PARP) on DNA by PARP inhibitor impair the repair of A3A-induced gaps, preferentially killing A3A-expressing cells. When used in combination, PARP and ATR inhibitors selectively kill A3A-expressing cells synergistically in a manner dependent on PrimPol-generated gaps. Thus, A3A-induced replication stress arises from PrimPol-generated ssDNA gaps, which confer a therapeutic vulnerability to gap-targeted DNA repair inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
- Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
- Department of Pathology, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Ajinkya S Kawale, Parasvi S Patel, Sneha Saxena, Michael S Lawrence, Lee Zou
Förderung
- NCI NIH HHS
Zitieren
APA
Kawale, A. S., Ran, X., Patel, P. S., Saxena, S., Lawrence, M. S., & Zou, L. (2024). APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. Science Advances, 10(3). https://doi.org/10.1126/sciadv.adk2771
Vancouver
Kawale AS, Ran X, Patel PS, Saxena S, Lawrence MS, Zou L. APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. Science Advances. 2024;10(3). doi:10.1126/sciadv.adk2771
BibTeX
@article{Kawale2024,
author = {Kawale, Ajinkya S and Ran, Xiaojuan and Patel, Parasvi S and Saxena, Sneha and Lawrence, Michael S and Zou, Lee},
title = {APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {3},
doi = {10.1126/sciadv.adk2771}
}
EUVIMED